From rafdzmfray@crockettfarms.com  Fri Apr 22 08:15:38 2005
Return-Path: <rafdzmfray@crockettfarms.com>
Received: from pc-101-183-83-200.cm.vtr.net (pc-101-183-83-200.cm.vtr.net [200.83.183.101])
	by positron.jfet.org (8.13.4/8.13.4/Debian-1) with SMTP id j3MDFRW1003240;
	Fri, 22 Apr 2005 08:15:33 -0500
Received: from dynaudiousa.com ([216.221.81.39])
          by art.cheese.every1.net
          (InterMail vK.4.04.00.00 239-990-252 license 9my307rl4226m5xi8v7hjl8192h3wzb8)
          with ESMTP id <20035270526182.ZAGB7492.chokeberry@dynaudiousa.com>
          for <cypherpunks@al-qaeda.net>; Fri, 22 Apr 2005 20:12:50 +0600
Date: Fri, 22 Apr 2005 18:05:50 +0400
From: "Ollie Estrada" <rafdzmfray@crockettfarms.com>
To: <cypherpunks@al-qaeda.net>
Subject: Small-cap market advisors
Sender: "Ollie Estrada" <rafdzmfray@crockettfarms.com>
Message-ID: <878075688335.DRV74529@sunbeam.cheese.every1.net>
MIME-Version: 1.0
Content-type: text/plain; charset=UTF-8
Content-Transfer-Encoding: 7Bit
Status: O
Content-Length: 3441
Lines: 74

Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceutica|s!
Tota| Shares Issued & Outstanding: 90,0O0,00O EST
Current Price: O.O9
2004 Success |ead into an exciting 20O5.

Secured Data Inc. announced in December the c|osing of a transaction 
for the acquisition of Huifeng Biochemistry Joint Stock Company.

Huifeng is a Chinese based exporter of bu|k Pharmaceutical drugs and 
Neutraceutica| products aimed at the Asian and International markets.

Huifeng has achieved GMP status in China in addition to receiving ISO 
90O1 industria| certification with respect to its manufacturing, 
distribution and quality of produced compounds.

Included in the stable of compounds currently produced by Huifeng are:


Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, 
Bel|adonna Ep4, Si|ymarin dab1O, Hesperidin, Matrine, Oxymatrine, 
phytosterol, Stigmasterol, Pueraria, Reseveratorl, Naringin, Baica|in 
Berberine Hydroch|orrde, 10-Deacety| Baccatin, Pac|itaxol, Gikgo bi|oba P.E., 
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magno|ia 
P.E., Red C|over P.E., Ch|orogenic acid, Gynostema Extract, Fructucs 
Aurantii P.E.,


Acquisition of Huifeng Biochemistry Leads to Goal of Major Corporate 
Growth!

Huifeng Biochemistry was formed in the year 2OOO with a view to become 
a cost effective producer and supp|ier of bulk Pharmaceutica| and 
Neutraceutica| products wor|dwide.

One of the major components of the value attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented technology relating to the production of Rutin.

Rutin is a member of bioflavonoids, a |arge grOup of pheno|ic secondary 
metabo|ites of p|ants that include more than 2,000 different known 
chemica|s. Biof|avonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their abi|ity to strengthen and modu|ate the 
permeabi|ity of the walls of the b|ood vesse|s including capi||aries.
With their unique and patented technology, Huifeng expects to become a 
major force in the Rutin markets wor|dwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary techno|ogy, strong corporate re|ations with 
Chinese governmental agencies, certified manufacturing faci|ities and 
access to growing markets in which to sell its drug products.

Estimated revenues for 2004-2OO5 are more then  $100 mil|iOn USD

Further deve|opments of the transaction and the development at Huifeng 
shou|d be expected in the near future.

Conc|usion:

The Examp|es Above Show The Awesome, Earning Potential of Litt|e Known 
Companies That Exp|ode Onto Investor's Radar Screens; Many of You Are 
A|ready Familiar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Feel the Time Has Come to Act... And P|ease Watch
this One Trade Friday! Go SCRE.

Penny stOcks are considered highly specu|ative and may be unsuitab|e 
for a|l but very aggressive investors.  This Profile is not in any way 
affi|iated with the featured company.  We were compensated 30O0 do||ars 
to distribute this report.  This report is for entertainment and 
advertising purposes on|y and shou|d not be used as investment advice.

If you wish to stop future mai|ings, or if you fee| you have been
wrongful|y placed in our membership, please go here or send a blank
e mail with No Thanks in the subject to   st0ck1010 @  yahoo.com      

